Lepri AC - Search Results

1

Risk of new AIDS diseases in people on triple therapy.

Miller V, Staszewski S, Nisius G, Lepri AC, Sabin C, Phillips AN. Miller V, et al. Among authors: lepri ac. Lancet. 1999 Feb 6;353(9151):463. doi: 10.1016/S0140-6736(98)04954-X. Lancet. 1999. PMID: 9989719 No abstract available.

2

When should antiretroviral therapy be started for HIV infection? Interpreting the evidence from observational studies.

Phillips AN, Lepri AC, Lampe F, Johnson M, Sabin CA. Phillips AN, et al. Among authors: lepri ac. AIDS. 2003 Sep 5;17(13):1863-9. doi: 10.1097/00002030-200309050-00004. AIDS. 2003. PMID: 12960818 Review. No abstract available.

3

CD4 lymphocyte count as a determinant of the time from HIV seroconversion to AIDS and death from AIDS: evidence from the Italian Seroconversion Study.

Phillips AN, Pezzotti P, Lepri AC, Rezza G. Phillips AN, et al. Among authors: lepri ac. AIDS. 1994 Sep;8(9):1299-305. doi: 10.1097/00002030-199409000-00013. AIDS. 1994. PMID: 7802984

4

The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997. Royal Free Centre for HIV Medicine.

Mocroft A, Barry S, Sabin CA, Lepri AC, Kinloch S, Drinkwater A, Lipman M, Youle M, Johnson MA, Phillips AN. Mocroft A, et al. Among authors: lepri ac. AIDS. 1999 Jul 9;13(10):1255-61. doi: 10.1097/00002030-199907090-00016. AIDS. 1999. PMID: 10416531

5

The virological response to highly active antiretroviral therapy over the first 24 weeks of therapy according to the pre-therapy viral load and the weeks 4-8 viral load.

Lepri AC, Miller V, Phillips AN, Rabenau H, Sabin CA, Staszewski S. Lepri AC, et al. AIDS. 2001 Jan 5;15(1):47-54. doi: 10.1097/00002030-200101050-00008. AIDS. 2001. PMID: 11192867

6

Early assessment of anti-HIV drug efficacy.

Paddam L, Sabin C, Lepri AC, Phillips A. Paddam L, et al. Among authors: lepri ac. Lancet. 2002 May 11;359(9318):1696-7; author reply 1697. doi: 10.1016/S0140-6736(02)08571-9. Lancet. 2002. PMID: 12020557 No abstract available.

7

Theoretical rationale for the use of sequential single-drug antiretroviral therapy for treatment of HIV infection.

Phillips AN, Youle MS, Lampe F, Johnson M, Sabin CA, Lepri AC, Loveday C. Phillips AN, et al. Among authors: lepri ac. AIDS. 2003 May 2;17(7):1009-16. doi: 10.1097/00002030-200305020-00009. AIDS. 2003. PMID: 12700450

8

Definition of loss of virological response in trials of antiretroviral drugs.

Staszewski S, Sabin C, Dauer B, Lepri AC, Phillips A. Staszewski S, et al. Among authors: lepri ac. AIDS. 2003 Sep 5;17(13):1997-8. doi: 10.1097/00002030-200309050-00024. AIDS. 2003. PMID: 12960838

9

Increased losses of CD4+CD45RA+ cells in late stages of HIV infection is related to increased risk of death: evidence from a cohort of 347 HIV-infected individuals.

Ullum H, Lepri AC, Victor J, Skinhøj P, Phillips AN, Pedersen BK. Ullum H, et al. Among authors: lepri ac. AIDS. 1997 Oct;11(12):1479-85. doi: 10.1097/00002030-199712000-00012. AIDS. 1997. PMID: 9342070

10

CD4 lymphocyte count as a predictor of the duration of highly active antiretroviral therapy-induced suppression of human immunodeficiency virus load.

Miller V, Staszewski S, Sabin C, Carlebach A, Rottmann C, Weidmann E, Rabenau H, Hill A, Lepri AC, Phillips AN. Miller V, et al. Among authors: lepri ac. J Infect Dis. 1999 Aug;180(2):530-3. doi: 10.1086/314890. J Infect Dis. 1999. PMID: 10395876

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters